PathGennie: New Computational Tool Speeds Up Drug Discovery Simulations

Scientists have developed PathGennie, a novel computational framework that can significantly accelerate the simulation of rare molecular events crucial for drug discovery. The findings have been published in the Journal of Chemical Theory and Computation.

Why It Matters for Drug Development
In pharmaceutical research, understanding a drug’s residence time—how long it remains bound to a target protein—is often more important than binding strength alone. However, simulating drug unbinding is extremely challenging, as these rare events occur over milliseconds to seconds, far beyond the reach of conventional molecular dynamics (MD) simulations.

Limitations of Existing Methods
Traditional approaches often rely on artificial bias forces or elevated temperatures to force rare events to occur. While effective in speeding up simulations, these techniques can distort the underlying physics, leading to inaccurate predictions of molecular pathways and drug behaviour.

How PathGennie Works
Developed by researchers at the S. N. Bose National Centre for Basic Sciences, Kolkata, PathGennie takes a fundamentally different approach. Instead of forcing molecular movement, it mimics natural selection at the microscopic level.

• It launches swarms of ultra-short, unbiased MD trajectories lasting only a few femtoseconds.
• Only those trajectories that naturally progress toward the desired outcome—such as drug unbinding—are selectively extended.
• This strategy preserves physical accuracy while dramatically reducing computational cost.

Implications for Computer-Aided Drug Discovery
As an open-source tool, PathGennie offers a major boost to computer-aided drug discovery (CADD). By accurately predicting unbinding pathways without artificial distortions, it can help researchers design more effective drugs and better understand drug–protein interactions.

Source: PIB